UAE Peptides is a leading provider of pharmaceutical-grade peptides, bioregulators and other small-molecule compounds within the Gulf Region.
Our products support innovation in regenerative medicine, longevity science, and immune restoration.
We are dedicated to delivering clinically trusted compounds that empower individuals, practitioners, and researchers to unlock the therapeutic potential of peptide and small-molecule science.
With a commitment to third-party testing, quality assurance, and global accessibility, we aim to help redefine health optimisation, one molecule at a time.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Business Bay, Blue Bay Tower,unit 1418,united Arab Emirates
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://uaepeptidesresearch.com/
- Keywords
- Methuselah Fund.
- HQ
- Dubai
Uae Peptides Questions
Uae Peptides's website is https://uaepeptidesresearch.com/
Uae Peptides's LinkedIn profile is https://ae.linkedin.com/company/uae-peptides
Uae Peptides has
2 employees.
View email and phone details for 2
employees at Uae Peptides.
Uae Peptides's industry is
Biotechnology Research
Uae Peptides's top competitors are
Protectwall Polycarbonate Antibacterial,
Arenalux,
The Beyond Tomorrow Podcast,
Longbio Institute,
Creative Peptides,
Jessica Alana,
Alpine Institute,
Al Noor Center For The Care Of Disabled,
Immuneage Bio,
Methuselah Fund.
Uae Peptides's categories are Biotechnology Research
Uae Peptides's founding year is 2022
